Business
Phase II SABRE prostate cancer trial reaches 50% recruitment
Phase II SABRE prostate cancer trial reaches 50% recruitment
About this update from Clarity Pharmaceuticals Ltd.
[{"type":"text","content":"Clarity Pharmaceuticals Ltd has released a press release. View Attachment","length":261,"tagName":"div"}]